A Cost-Effective Interdisciplinary Approach to Microbiologic Send-Out Test Use

Size: px
Start display at page:

Download "A Cost-Effective Interdisciplinary Approach to Microbiologic Send-Out Test Use"

Transcription

1 A Cost-Effective Interdisciplinary Approach to Microbiologic Send-Out Test Use Scott W. Aesif, MD, PhD; David M. Parenti, MD; Linda Lesky, MD; John F. Keiser, MD, PhD Context. Use of reference laboratories for selected laboratory testing (send-out tests) represents a significant source of laboratory costs. As the use of more complex molecular analyses becomes common in the United States, strategies to reduce costs in the clinical laboratory must evolve in order to provide high-value, cost-effective medicine. Objective. To report a strategy that employs clinical pathology house staff and key hospital clinicians in the effective use of microbiologic send-out testing. Design. The George Washington University Hospital is a 370-bed academic hospital in Washington, DC. In 2012 all requisitions for microbiologic send-out tests were screened by the clinical pathology house staff prior to final dispensation. Tests with questionable utility were brought to the attention of ordering clinicians through the use of interdisciplinary rounds and direct face-to-face consultation. Results. Screening resulted in a cancellation rate of 38% of send-out tests, with proportional cost savings. Nucleic acid tests represented most of the tests screened and the largest percentage of cost saved through screening. Following consultation, requested send-out tests were most often canceled because of a lack of clinical indication. Conclusions. Direct face-to-face consultation with ordering physicians is an effective, interdisciplinary approach to managing the use of send-out testing in the microbiology laboratory. (Arch Pathol Lab Med. 2015;139: ; doi: / arpa oa) Understanding the economic strain of health care costs to 30% of ordered tests are redundant or inadvertently in the United States is complicated by estimates that repeated. 4,5 These tests have little or no impact on the as much as 30% of the delivered health care in the United hospital course of the patient, save the cost of the test. States is duplicative or unnecessary. 1 To encourage the However, unnecessary laboratory investigations can trigger profession to improve its stewardship of health care expensive and/or invasive diagnostic work-ups or therapies. resources, health care leaders have proposed adding a In the inpatient setting, reference testing represents a seventh general competency, cost-consciousness and direct upfront cost to the laboratory. When billed as part of a stewardship of resources, to the current six competencies diagnosis-related group, it is difficult to recover a significant defined by the Accreditation Council for Graduate Medical portion of these costs. A common cost-containment strategy Education and the American Board of Medical Subspecialties. However, a recent survey of practicing physicians review of reference laboratory tests. 6 This approach is at some academic institutions is the pathologist-conducted found that only a third of those surveyed thought that traditionally thought of as time-consuming and most physicians bear the responsibility for controlling health care applicable to teaching hospitals, where the task of vetting costs. 3 send-out tests is delegated to the clinical pathology resident. There are scant data with regard to what types of tests are Diagnostic testing often occurs early in the care and most often being screened by pathology house staff and the management of hospitalized patients, and much of its clinical rationale behind order modifications. We therefore financial impact is determined by how the test result affects employed an interdisciplinary approach to screening microbiologic send-out tests in order to assess cost impact and the hospital course of the patient. Estimates suggest that up clinical rationale. Accepted for publication March 19, Published as an Early Online Release April 23, MATERIALS AND METHODS From the Department of Pathology (Drs Aesif and Keiser), and the The George Washington University Hospital is a 370-bed tertiary Divisions of Infectious Diseases (Dr Parenti) and Hospital Medicine care hospital located in downtown Washington, DC. For the last 15 (Dr Lesky), Department of Medicine, The George Washington years, we have routinely employed a resident or house staff based University, Washington, DC. approach to screening reference laboratory testing. Using this The authors have no relevant financial interest in the products or companies described in this article. approach, the client services division of the core laboratory requires Presented in poster format at the 2012 annual meeting of the that all microbiologic send-out tests be reviewed by the clinical American Society for Clinical Pathology; November 2, 2013; Boston, pathology house staff prior to being sent to the reference Massachusetts. laboratory, regardless of test type or cost. In the last year we Reprints:JohnF.Keiser,MD,PhD,DepartmentofPathology,The adopted a more interdisciplinary approach to screening send-out George Washington University, 2100W Pennsylvania Ave NW, Ste 5027, Washington, DC ( jkeiser@mfa.gwu.edu). test requests. Key clinicians were identified who could facilitate communication with ordering physicians. These individuals were 194 Arch Pathol Lab Med Vol 139, February 2015 Microbiologic Send-Out Tests Aesif et al

2 Table 1. A Summary of All Send-Out Test Requisitions Screened by Pathology House Staff and Faculty in 2012, Categorized by Test Type and With Associated Cancellation Percentages and Cost Savings Test Type Orders Percent Cost Saved Percent of Cost Saved Nucleic acid tests $48, Serology and culture $5, $53, identified using service-based test-ordering totals and the likelihood that they would be caring for any one patient for whom microbiologic send-out tests were ordered. Using those criteria we approached the Department of Medicine s Divisions of Hospital Medicine and Infectious Diseases. In discussing the laboratory s role in the usage management of send-out tests, we asked that these individuals facilitate communication with ordering clinical services. This was accomplished in a number of ways, including but not limited to: introduction of pathology faculty and house staff to clinical teams, provision of clinical round times and locations, and facilitation of pathology faculty and house staff participation in patient rounds. As client services staff receive orders for send-out microbiologic tests, they are held in the laboratory and delivered to the clinical pathology house staff once or twice daily, with a range of 0 to 12 requisitions daily. The test requisitions are then used to review patients electronic medical records for pertinent history and laboratory data. Finally, rather than attempt to call or page the ordering physician, test requisitions are taken directly to the wards and emergency department for discussion. 7,8 In addition, for those test requisitions not addressed by the method described above, clinical house staff members are engaged as part of microbiology-specific rounds that are held 5 times a week in the microbiology laboratory. These rounds are attended by medicine and infectious diseases house staff and occasionally attending physicians, and are led by the clinical pathology house staff and attending microbiologist. As a result of these face-to-face discussions and laboratory rounds, tests are approved, modified, or canceled. All send-out test requisitions for calendar year 2012 were archived, and data regarding order date, ordering service, the indication for order modification, and the ultimate dispensation of the test were recorded. Cost analyses were performed using the price per test as negotiated by The George Washington University Hospital with an extramural reference laboratory. These prices represent direct billing charges to The George Washington University Hospital by the extramural reference laboratory. All of the data presented herein represent orders placed for inpatient services only. No tests were canceled without prior discussion with a treating physician. All study methods were approved by the Institutional Review Board at The George Washington University. Data and statistical analyses were performed using Microsoft Excel software (Microsoft Corporation, Redmond, Washington). A detailed analysis of nucleic acid test requisitions demonstrated that most nucleic acid tests were ordered for the detection of viral pathogens (93%, or 740 tests). The remaining nucleic acid tests were ordered for the detection of bacterial pathogens (7%, or 57 tests). Hepatitis C virus (225 tests) and herpes simplex virus (138 tests) represented the largest proportion of total nucleic acid tests ordered and reviewed (Table 2). The hepatitis C virus test requisitions were further analyzed to reveal that 30% of all of the hepatitis C virus nucleic acid tests were ordered with either a negative antibody screening test or concomitantly with an antibody screening test that was ultimately negative. Of all the hepatitis C virus nucleic acid tests ordered, 31% did not require modification prior to final dispensation. The herpes simplex virus test requisitions were further analyzed to Table 2. Detailed List of Screened Nucleic Acid Tests a Test Name Orders Percent Borrelia spp, DNA, qualitative Cytomegalovirus virus, DNA, qualitative Epstein-Barr virus, DNA, qualitative Epstein-Barr virus, DNA, quantitative Enterovirus, RNA, qualitative HIV-1, genotype HIV-1, DNA, qualitative HIV-1, RNA, quantitative Hepatitis B virus, DNA, qualitative Hepatitis B virus, DNA, quantitative Hepatitis C virus, genotype Hepatitis C virus, RNA, qualitative Hepatitis C virus, RNA, quantitative RESULTS Summary of Reviewed Send-Out Tests and Cost Savings Analysis Varicella zoster virus, DNA, HSV 1 and 2, DNA, qualitative JC virus, DNA, qualitative qualitative During the course of 1 year, the clinical pathology house West Nile virus, RNA, staff reviewed a total of 1207 microbiologic send-out test qualitative requisitions (Table 1). tests represented a total savings of $53, in direct cost to the laboratory. All of Other (,5 total annual orders) the data in Table 1 exclude the cost of in-house labor and supplies. The average unit cost per canceled reference test was $117 per test. A survey of all clinical pathology house Abbreviations: HIV, human immunodeficiency virus; HSV, herpes simplex virus. a A detailed summary of all nucleic acid send-out test requisitions staff found the average amount of time needed to review screened by pathology house staff and faculty in 2012 is given; the tests are listed by name with associated cancellation percentages. The send-out test requisitions and meet with clinical staff to be other category of nucleic acid send-out tests included: BK virus, 71 (629) minutes per day (n ¼ 15 residents), including dengue fever virus, parvovirus, and Pneumocystis jirovecii amplification rounds held in the microbiology laboratory. assays. Arch Pathol Lab Med Vol 139, February 2015 Microbiologic Send-Out Tests Aesif et al 195

3 Table 3. Test Name Detailed List of Screened Serologic Tests and Cultures a Orders Percent Adenosine deaminase Aspergillus spp, antigen Bacterial meningitis, antigen panel Bartonella spp, Ig Cytomegalovirus, Ig Coxsackie virus, Ig Dengue fever virus, Ig Epstein-Barr virus, Ig Hepatitis B virus, e antigen Histoplasma spp, antigen Herpes simplex virus, culture Borrelia spp, Ig and WB Mycoplasma pneumoniae, Ig Parvovirus B19, Ig Toxoplasma gondii, Ig West Nile virus, Ig Other (,5 total annual orders) Abbreviations: Ig, immunoglobulin, including IgG, IgM, and/or total; WB, Western blot analysis. a A detailed summary of all serologic and culture send-out test requisitions screened by pathology house staff and faculty in 2012 is given; the tests are listed by name with associated cancellation percentages. The other category of serologic and culture send-out tests included: adenovirus, Bordetella spp, Coccidioides spp, Coxiella spp, Cryptococcus spp, DNase B, Echinococcus spp, Entamoeba histolytica, Ehrlichia spp, hepatitis A virus, human T-lymphocyte virus, Rickettsia spp, rubella virus, Trichinella spp, and Western equine encephalomyelitis virus Ig assays. Antigen assays included: beta-dglucan, Cryptococcus spp, Giardia spp, Legionella spp, norovirus, and Streptococcus pneumoniae. reveal that 76% of all of the herpes simplex virus nucleic acid tests were ordered on cerebrospinal fluid specimens. Of those cerebrospinal fluid specimens, 72% had normal white blood cell counts, and 46% had normal white blood cell counts, glucose concentration, and total protein concentration, as defined by our laboratory s reference intervals. A detailed analysis of serology and culture test requisitions demonstrated that most tests were ordered for the detection of viral pathogens (51%, or 210 tests) and bacterial pathogens (27%, or 112 tests). The remaining tests were ordered for the detection of fungal (12%, or 49 tests), protozoal (7%, or 29 tests), and parasitic pathogens (3%, or 10 tests). Epstein-Barr virus immunoglobulins (51 tests) and a bacterial meningitis antigen agglutination panel (47 tests) represented the largest proportion of total serology and culture tests ordered and reviewed (Table 3). Stratification of Ordered and Tests by Ordering Department and Consultation Status An analysis of the total number of send-out microbiologic tests ordered by individual departments demonstrated that most time spent in consultation by the pathology house staff was focused on a handful of clinical departments (Figure, A and B). Further analysis revealed that if the Division of Infectious Diseases had been consulted on patients for whom a test request was being reviewed, the dispensation was more likely to be canceled (P,.001, v 2 test; Figure, C and D). Rationale for Test Cancellation All canceled requisitions were determined to have been canceled for preanalytic reasons. 9 The requisitions were further categorized based on the fundamental rationale behind canceling the order. Three categories were used: clinical indication, order entry error, and follow-up. The clinical indication category represented 65% of canceled tests and included such reasons as: a confirmation test ordered in the absence of a screening test order, a confirmation test ordered with a negative screening test result, and a change in clinical status and/or clinical history. The order entry error category represented 35% of canceled tests and included such reasons as: mistaken orders, duplicate orders, incorrectly inputted test orders, and insufficient specimen quantity. The follow-up category represented rare insistences, 0.2% of canceled tests, when patients were discharged prior to a test being screened by the pathology house staff and the ordering physician determined that the test be followed up in the outpatient setting. COMMENT Previous studies have estimated the average cost of reference tests to be $26 to $46; however, our data suggest an average cost per microbiologic reference test to be $ ,11 The rapid emergence of molecular diagnostic reference testing portends an even greater relative contribution to overall health care cost. There are limited published data from which to assert that our cancellation rate or service ordering trends for microbiologic send-out tests are consistent with those of other United States or international institutions. 10,12 However, in a recent workgroup publication the American College of Physicians highlighted microbiologic screening tests in a list of clinical situations in which testing does not reflect high-value care. 7 It has been demonstrated that the formation of formal oversight committees can effectively reduce laboratory send-out test expenditures when there is active involvement by medical staff. 13,14 We demonstrate that simple face-toface interdisciplinary communication between pathology and either infectious diseases or hospitalist medical staff is a cost-effective method in itself for ensuring high-value sendout test use, and that pathologists can engage with clinicians regularly enough to actively influence diagnostic testing and patient management decisions. Furthermore, the benefits of such an approach to clinical pathology house staff and medical staff were tangible. There was no resistance to test review on the part of the ordering clinicians, given that this has been standard practice in the microbiology department for the greater part of two decades. In addition to the educational benefits reaped by pathology house staff with regard to testing methods and interpretation, medical staff were equally engaged in active learning. Similarly, we believe such an approach helps to prepare clinical house staff to constructively deal with future questions they may face as attending physicians regarding their send-out test requisitions. Furthermore, data shown in Figure 1 suggest that when pathology house staff could use key clinical services, such as infectious diseases and hospitalists, as a portal to the clinical staff treating the patient, the likelihood 196 Arch Pathol Lab Med Vol 139, February 2015 Microbiologic Send-Out Tests Aesif et al

4 All send-out test requisitions screened by pathology house staff and faculty in 2012, presented as either total tests ordered (A and C) or canceled tests (B and D). The tests are broken down by ordering department (A and B) and whether the Division of Infectious Diseases had consulted on the patient for whom a send-out test had been ordered (C and D; *P,.001). The other department category included: cardiology, interventional radiology, neurologic surgery, orthopedic surgery, general surgery, obstetrics and gynecology, and nephrology. Abbreviations: ED, emergency department; ID, Division of Infectious Diseases. was higher that a send-out test order would ultimately be modified or reconsidered. Our estimated time commitment per test screened (approximately 15 minutes) is longer than was estimated in a recent, more administrative-based intervention. 12 The advantage with our approach is that the review of send-out tests happens essentially in real time. This avoids the perception on the part of the clinical staff that such a review is delaying patient care, and allows the pathology house staff to get the most up-to-date patient information. Similarly, face-to-face interaction makes for fruitful and collegial discussion. Our data demonstrate that although order entry errors make up a significant fraction of canceled send-out tests, most send-out tests were canceled following interdisciplinary discussion of the patient s clinical findings. This type of discussion is challenging to have by impersonal electronic or telephone communication. The general applicability of the current study is somewhat limited to the inpatient setting. The fee-for-service reimbursements sought in the outpatient setting are not relevant to the per diem reimbursements sought for the inpatient services examined herein. Therefore, the cost savings estimated by this study are thought to represent direct savings through avoidable and unnecessary charges to the hospital from extramural reference laboratories. Similarly, the practice of screening reference laboratory tests need not apply only to the academic hospital with resident house staff. This type of consultation represents a leadership role for pathologists to take in the era of more sophisticated and costly molecular testing. Because most clinicians do not currently have the time to provide such a service, it is unlikely that in the future they will find the necessary time or knowledge base to do so on their own. Furthermore, in anticipation of bundled payments for care, prevention of avoidable or unnecessary testing represents a modality wherein the pathologist can effectively demonstrate his or her value to patient care. Pathologists can proactively reach beyond the laboratory to help manage the appropriate use of testing and drive appropriate postanalytic interpretation of test results and clinical decision making, but they must do so in conjunction and collaboration with clinicians in order to ensure the most appropriate cost-effective patient care. References 1. Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds.; National Research Council. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: National Academies Press; Weinberger SE. Providing high-value, cost-conscious care: a critical seventh general competency for physicians. Ann Intern Med. 2011;155(6): Tilburt JC, Wynia MK, Sheeler RD, et al. Views of US physicians about controlling health care costs. JAMA. 2013;310(4): van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem. 2003;49(12): Bates DW, Boyle DL, Rittenberg E, et al. What proportion of common diagnostic tests appear redundant? Am J Med. 1998;104(4): Carter E, Bennett BD. Reference test review by pathology house staff: a cost-containment strategy for the clinical laboratory. Clin Leadersh Manag Rev. 2002;16(1): Qaseem A, Alguire P, Dallas P, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012; 156(2): Arch Pathol Lab Med Vol 139, February 2015 Microbiologic Send-Out Tests Aesif et al 197

5 8. Laine C. High-value testing begins with a few simple questions. Ann Intern Med. 2012;156(2): Hawkins R. Managing the pre- and post-analytical phases of the total testing process. Ann Lab Med. 2012;32(1): MacMillan D, Lewandrowski E, Lewandrowski K. An analysis of reference laboratory (send out) testing: an 8-year experience in a large academic medical center. Clin Leadersh Manag Rev. 2004;18(4): Valenstein PN, Praestgaard AH, Lepoff RB. Six-year trends in productivity and utilization of 73 clinical laboratories: a College of American Pathologists laboratory management index program study. Arch Pathol Lab Med. 2001;125(9): Liu Z, Abdullah A, Baskin L, Lewis G, Kelter G, Naugler C. An intervention to reduce laboratory utilization of referred-out tests. Lab Med. 2012;43(5): Zhao JJ, Liberman A. Pathologists roles in clinical utilization management: a financing model for managed care. Am J Clin Pathol. 2000;113(3): Warren JS. Laboratory test utilization program: structure and impact in a large academic medical center. Am J Clin Pathol. 2013;139(3): Arch Pathol Lab Med Vol 139, February 2015 Microbiologic Send-Out Tests Aesif et al

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations Dear User, ISSUE: M008 DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations In order to comply with national quality guidance and as part of our

More information

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.

Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress

More information

Test Requested Specimen Ordering Recommendations

Test Requested Specimen Ordering Recommendations Microbiology Essentials Culture and Sensitivity (C&S) Urine C&S Catheter Surgical (excluding kidney aspirates) Voided Requisition requirements o Specific method of collection MUST be indicated o Indicate

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

Microbiology EQA Product Portfolio

Microbiology EQA Product Portfolio Labquality EQAS Microbiology EQA Product Portfolio Clinically relevant external quality assessment program for microbiology Bacterial serology Bacteriology Mycology Parasitology Preanalytics Virology Labquality

More information

Immunohistochemical Confirmation of Infections

Immunohistochemical Confirmation of Infections Immunohistochemical Confirmation of Infections Danny A. Milner, Jr, MD, MSc, FCAP The Brigham and Women s Hospital Harvard Medical School Boston, Masschusetts USA Judicious Use of Immunohistochemistry

More information

Programme Groupings. For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group.

Programme Groupings. For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group. Equalis EQA s 2013 Preliminary Schedule For 2013, the preliminary molecular external quality assessment (EQA) programme schedule has been displayed by Disease Group. Note: EQA programmes may appear in

More information

Test Definition: FMCPS Meningoencephalitis Comprehensive Panel (Serum)

Test Definition: FMCPS Meningoencephalitis Comprehensive Panel (Serum) Reporting Title: Meningoencephalitis Comp Panel, S Performing Location: Focus Diagnostics, Specimen Requirements: Draw blood in a plain, red-top tube(s). (Serum gel tube is acceptable.) Spin down and send

More information

Montgomery County Community College BIO 241 Clinical Microbiology II 4-3-3

Montgomery County Community College BIO 241 Clinical Microbiology II 4-3-3 Montgomery County Community College BIO 241 Clinical Microbiology II 4-3-3 AY16-17 COURSE DESCRIPTION: A course that introduces Immunology, Virology, Mycology, and Parasitology as well as the immunological

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Identification of Microorganisms Using Nucleic Acid Probes File Name: Origination: Last CAP Review: Next CAP Review: Last Review: identification_of_microorganisms_using_nucleic_acid_probes

More information

Cerebrospinal Fluid in CNS Infections

Cerebrospinal Fluid in CNS Infections Cerebrospinal Fluid in CNS Infections Osvaldo M. Takayanagui Departamento de Neurologia Faculdade de Medicina de Ribeirão Preto Universidade de São Paulo Diagnosis of CNS Infections 1891- Heinrich Quincke

More information

Preventing Genetic Testing Order Errors With a Laboratory Utilization Management Program

Preventing Genetic Testing Order Errors With a Laboratory Utilization Management Program AJCP /ORIGINAL ARTICLE Preventing Genetic Testing Order Errors With a Laboratory Utilization Management Program Patrick C. Mathias, MD, PhD, 1 Jessie H. Conta, MS, 2 Eric Q. Konnick, MD, 1 Darci L. Sternen,

More information

Perform Gram stain only. Select Survey D5, Gram Stain

Perform Gram stain only. Select Survey D5, Gram Stain www.cap.org Bacteriology This flowchart is provided as a guide for ordering the appropriate Bacteriology Surveys for your laboratory s testing menu. In order to meet CLIA requirements for the subspecialty

More information

infectious disease Serological testing in a microbiology laboratory of specimens from patients with suspected

infectious disease Serological testing in a microbiology laboratory of specimens from patients with suspected 358 35 Clin Pathol 1995;48:358-363 Department of Microbiology, Wycombe General Hospital, Queen Alexandra Road, High Wycombe HP11 2TT D J Waghorn Correspondence to: Dr D J Waghom. Accepted for publication

More information

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada Canada Communicable Disease Report ISSN 1188-4169 Date of publication: October 1998 Volume 24S7 Supplement Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada 1989 to 1996 Our

More information

Lemuel Shattuck Hospital Consultation Service

Lemuel Shattuck Hospital Consultation Service Lemuel Shattuck Hospital Consultation Service a) Goals, Objectives, and ACGME Competencies Goals Learn how to manage complicated infectious disease problems in a public health setting. Learn how to provide

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006

More information

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS Take Control, Molecular Control. 02 04 05 06 06 07 08 08 AMPLIRUN TOTAL RESPIRATORY INFECTIONS TUBERCULOSIS INFECTIONS GASTROINTESTINAL

More information

Memo No: Date: 25-Nov NEW Serology and Virology Testing

Memo No: Date: 25-Nov NEW Serology and Virology Testing Memo No: 2014-61 Date: 25-Nov-2014 www.hicl.on.ca Re: NEW Serology and Virology Testing In Common Laboratories has been working hard to expand our test menu. We are pleased to announce the availability

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not

More information

الحترمونا من خري الدعاء

الحترمونا من خري الدعاء الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

July Billing and Compliance. Chemistry. Help Us Help You. Referral Testing

July Billing and Compliance. Chemistry. Help Us Help You. Referral Testing July 2018 Billing and Compliance New Medicare card mailings have begun for Minnesota and Wisconsin residents Chemistry Beta hydroxybutyrate, whole blood specimen requirement change Help Us Help You Preventing

More information

Potential Reimbursement CPT Codes

Potential Reimbursement CPT Codes BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may

More information

Infections in immunocompromised host

Infections in immunocompromised host Infections in immunocompromised host Immunodeficiencies Primary immunodeficiencies Neutrophil defect Humoral: B cell defect Humoral: Complement Cellular: T cells Combined severe immunodeficiency Secondary

More information

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of

More information

Non-reproductive tissues and cells Recommending authority/ association

Non-reproductive tissues and cells Recommending authority/ association Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique

More information

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on

More information

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory This appendix contains a list of agents that, when reasonably anticipated to be present, require a laboratory to comply

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen

More information

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University

More information

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario Increase in Locally-Acquired Cyclosporiasis Cases in Ontario Update to York Region health care providers as of July 31, 2018 Ontario is experiencing an increase in the number of Cyclospora infections.

More information

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p.

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p. Extract Vademecum Department of Medical Microbiology Status: Code: Version: Approval date: Geldig MMB-PR-04/1 1 Juni 2017 Name request Specimen Material needed Transport Bacteriology Bacterial culture

More information

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes

More information

USA Product Listing. Serology Diagnostic Products

USA Product Listing. Serology Diagnostic Products USA Product Listing Serology Diagnostic Products Focus Diagnostics recognizes your testing needs because we identify and evaluate trends in diagnostic testing. The products listed in this brochure were

More information

1) understand the structure and life cycle of viruses as well as viral evolution. 2) know the mechanisms of host immune responses to viral infections

1) understand the structure and life cycle of viruses as well as viral evolution. 2) know the mechanisms of host immune responses to viral infections VIROLOGY A The course aims to provide the student with the cognitive and methodological tools necessary to: 1) understand the structure and life cycle of viruses as well as viral evolution 2) know the

More information

Geriatric Neurology Program Requirements

Geriatric Neurology Program Requirements Geriatric Neurology Program Requirements Approved November 8, 2013 Page 1 Table of Contents I. Introduction 3 II. Institutional Support 3 A. Sponsoring Institution 3 B. Primary Institution 4 C. Participating

More information

Controls & Calibrators. Disease Quality Controls

Controls & Calibrators. Disease Quality Controls Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted

More information

Appropriate utilization of the microbiology laboratory. 11 April 2013

Appropriate utilization of the microbiology laboratory. 11 April 2013 Appropriate utilization of the microbiology laboratory 11 April 2013 Lecture Plan Revision of infectious disease Triad of infectious disease Interaction between host and infectious agent Pathogenesis Phases

More information

IP Lab Webinar 8/23/2012

IP Lab Webinar 8/23/2012 2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Microbiology Department Contact: Dr David Ashburn Zone 3 Raigmore Hospital Tel: +44 (0) 1463 704108 Old Perth Road Fax: +44 (0) 1463 705648

More information

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular

More information

Some medical conditions require exclusion from school or child care to prevent the spread of infectious diseases among staff and children.

Some medical conditions require exclusion from school or child care to prevent the spread of infectious diseases among staff and children. Policies - Time Out - Department of Health Exclusion Periods Some medical conditions require exclusion from school or child care to prevent the spread of infectious diseases among staff and children. This

More information

Section 1 has been repealed by Decree of 30 December 2003/1383.

Section 1 has been repealed by Decree of 30 December 2003/1383. Ministry of Social Affairs and Health, Finland Unofficial translation No. 786/1986 Communicable Diseases Decree Issued on 31 October 1986 Section 1 has been repealed by Decree of 30 December 2003/1383.

More information

Canadian College of Microbiologists. Syllabus for Examination Preparation for Fellows in Clinical Microbiology (FCCM)

Canadian College of Microbiologists. Syllabus for Examination Preparation for Fellows in Clinical Microbiology (FCCM) Canadian College of Microbiologists Syllabus for Examination Preparation for Fellows in Clinical Microbiology (FCCM) This syllabus has been prepared as a study guide for the written and oral components

More information

The Study of Congenital Infections. A/Prof. William Rawlinson Dr. Sian Munro

The Study of Congenital Infections. A/Prof. William Rawlinson Dr. Sian Munro The Study of Congenital Infections A/Prof. William Rawlinson Dr. Sian Munro Current Studies SCIP Study of Cytomegalovirus (CMV) Infection in Pregnancy ASCI Amniotic Fluid Study of Congenital Infections

More information

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 Didactic Series Primary HIV Infection Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council

More information

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 5202 CHAPTER... AN ACT

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 5202 CHAPTER... AN ACT 77th OREGON LEGISLATIVE ASSEMBLY--2014 Regular Session Enrolled House Bill 5202 Sponsored by JOINT COMMITTEE ON WAYS AND MEANS CHAPTER... AN ACT Relating to state financial administration; and declaring

More information

Structure and duties of Blood service

Structure and duties of Blood service NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,

More information

GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM

GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM Psychiatry is a medical specialty that is focused on the prevention, diagnosis, and treatment of mental, addictive, and emotional disorders throughout the

More information

In the setting of measles elimination in the United States, the current measles case definition lacks specificity.

In the setting of measles elimination in the United States, the current measles case definition lacks specificity. 12-ID-07 Committee: Infectious Disease Title: Public Health Reporting and ational otification for Measles I. Statement of the Problem In the setting of measles elimination in the United States, the current

More information

Panel # Panel CPT Code Price 2010 AUTOIMMUNE PROFILE - BASIC 99.00

Panel # Panel CPT Code Price 2010 AUTOIMMUNE PROFILE - BASIC 99.00 2010 AUTOIMMUNE PROFILE - BASIC 99.00 Anti-Nuclear Antibody (ANA) 86038 33.00 Rheumatoid Factor 86431 33.00 C1Q Immune Complex 86332 33.00 2011 AUTOIMMUNE PROFILE (COMPREHENSIVE) 210.00 Anti-Nuclear Antibody

More information

Version number CAT 2016/01

Version number CAT 2016/01 Version number CAT 2016/01 Contents An Introduction to the QCMD EQA Schemes 4 Disease Groups Blood Borne Virus 5 Central Nervous System 5 Congenital Infections 6 Drug Resistance 6 Exotic/Emerging Diseases

More information

PHAR 6724: Introduction to the Immune System and Infectious Disease

PHAR 6724: Introduction to the Immune System and Infectious Disease PHAR 6724: Introduction to the Immune System and Infectious Disease Course Syllabus Spring 2018 3.1 Credits This course adheres to the items listed in the College of Pharmacy Central Syllabus: https://docs.google.com/a/umn.edu/document/d/1artq5e1rbzxe8letwo7be8k8snzaegmmz_qcw8yj-ii/edit?pli=1

More information

ELISA. AccuDiag Autoimmune Diseases and Others. ANA Screen Qualitative ~135 min 90.4% 100%

ELISA. AccuDiag Autoimmune Diseases and Others. ANA Screen Qualitative ~135 min 90.4% 100% / AccuDiag Autoimmune Diseases and Others ANA Screen 5102-2 96 ~135 min 90.4% 100% ENA Profile-6 (Sm/RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) 2506-2 96 ~ 60 min 96% 100% ENA Combined Screen (6 antigens) Sm/RNP,

More information

Viral Diseases. T Bamdad, PhD, Tarbiat Modares University

Viral Diseases. T Bamdad, PhD, Tarbiat Modares University Viral Diseases 1 Categorizing viral infections by the organ system most commonly affected (eg, lungs, GI tract, skin, liver, CNS, mucous membranes) can be clinically useful, although certain viral disorders

More information

BioPlex 2200 Infectious Disease Panels

BioPlex 2200 Infectious Disease Panels BioPlex 2200 System BioPlex 2200 Infectious Disease Panels An Expanding Multiplexed Assay Menu Lyme HIV Ag-Ab MMV IgM Syphilis Total & RPR MMRV EBV HSV-1 & HSV-2 EBV IgM ToRC IgM ToRC Leading the way with

More information

TEST REQUEST INFORMATION- VIROLOGY

TEST REQUEST INFORMATION- VIROLOGY Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport

More information

Halton Region Health Department Vol 13, Issue 2 Summer 2006 To all Halton Physicians The following topics are included in this update: West Nile Virus Update Update on Mumps Hepatitis B Immunization for

More information

Infection Control Manual Residential Care Part 3 Infection Control Standards IC6: Additional Precautions

Infection Control Manual Residential Care Part 3 Infection Control Standards IC6: Additional Precautions IC6: 0110 Appendix I Selection Table Infection Control Manual esidential Care IC6: Additional Legend: outine Practice * reportable to Public Health C - Contact ** reportable by Lab D - Droplet A - Airborne

More information

Submitted by: Fred Medrano, Director, Department of Health Services

Submitted by: Fred Medrano, Director, Department of Health Services Office of the City Manager ACTION CALENDAR November 17, 2009 To: From: Honorable Mayor and Members of the City Council Phil Kamlarz, City Manager Submitted by: Fred Medrano, Director, Department of Health

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles

More information

Syndromic Testing for Infectious Diseases

Syndromic Testing for Infectious Diseases Syndromic Testing for Infectious Diseases Part 3: Central Nervous System Infections HOT TOPIC / 2017 Presenter: Elitza S. Theel, Ph.D., D(ABMM) Director of Infectious Diseases Serology Department of Laboratory

More information

INFECTIOUS DISEASES POLICY

INFECTIOUS DISEASES POLICY Purpose The purpose of this policy is to ensure that the control of infectious diseases and contagious conditions are effectively addressed through both preventative and management strategies. Scope This

More information

Non-reproductive tissues and cells

Non-reproductive tissues and cells Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding

More information

12/10/ Immediate Action, Quest Diagnostics Nichols Institute, Valencia

12/10/ Immediate Action, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

Cytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy

Cytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy Infectious Disease Cytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy FOR OUTSIDE THE US AND CANADA ONLY Confidence in Your Results LIAISON Cytomegalovirus

More information

Size nm m m

Size nm m m 1 Viral size and organization Size 20-250nm 0.000000002m-0.000000025m Virion structure Capsid Core Acellular obligate intracellular parasites Lack organelles, metabolic activities, and reproduction Replicated

More information

Cost drivers in Microbiology/Serology laboratory testing: some perspectives

Cost drivers in Microbiology/Serology laboratory testing: some perspectives Cost drivers in Microbiology/Serology laboratory testing: some perspectives Dr S Hajee Consultant Microbiologist VERIPATH 1 introduction Consensus on the need and desirability to reduce the money spent

More information

MICROBIOLOGICAL TESTING IN PICU

MICROBIOLOGICAL TESTING IN PICU MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug

More information

Integrating HIV Screening Into

Integrating HIV Screening Into MaxiMizing Third ParTy reimbursement for hiv TesTing Integrating HIV Screening Into Title X Services IntroductIon HIV screening services are a core family planning service, and all individuals aged 13-64

More information

Wherever possible it is recommended that a child receive their vaccination on a day when they will not be attending the centre..

Wherever possible it is recommended that a child receive their vaccination on a day when they will not be attending the centre.. Policy Hierarchy link Responsible Officer Contact Officer Superseded Documents Children (Education and Care Services National Law Application) Act 2010 Education and Care Services National Regulations

More information

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval

More information

Code CPT Descriptor Test Purpose and Method Crosswalk Recommendation SEPT9 (Septin9) (e.g., colorectal cancer) methylation analysis

Code CPT Descriptor Test Purpose and Method Crosswalk Recommendation SEPT9 (Septin9) (e.g., colorectal cancer) methylation analysis ASSOCIATION FOR MOLECULAR PATHOLOGY Education. Innovation & Improved Patient Care. Advocacy. 9650 Rockville Pike. Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7995 amp@amp.org www.amp.org August

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 39, 2018 (Notification

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Issue No: 001 Issue date: 28 September 2018 Department of Microbiology Contact: Diane Matley Level B Tel: +44 (0)23 8120 6408 Pathology Block E-Mail: Diane.Matley@uhs.nhs.uk Southampton General Hospital

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 33, 2018 (Notification

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 49, 2018 (Notification

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Clinical Microbiology QMC Campus Derby Road Nottingham NG7 2UH Contact: Jil Bowskill Tel: +44 (0) 1905 760192 Ext 30659 E-Mail: jilean.bowskill@nuh.nhs.uk

More information

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 38, 2018 (Notification

More information

INFECTIOUS DISEASE. Page 2

INFECTIOUS DISEASE. Page 2 Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic

More information

EPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE

EPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE 23 March, 2018 EPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE Document Filetype: PDF 227.63 KB 0 EPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE Epstein-Barr Virus can trigger seven autoimmune diseases

More information

M O L E C U L A R G E N E T I C S

M O L E C U L A R G E N E T I C S MOLECULAR GENETICS ADVANTAGES OF MOLECULAR GENETICS Molecular genetics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are

More information

The Division of Renal Diseases and Hypertension. Fellowship Program

The Division of Renal Diseases and Hypertension. Fellowship Program The Division of Renal Diseases and Hypertension Fellowship Program John R. Foringer, M.D. Program Director Amber S. Podoll, M.D. Associate Program Director The primary goal of the Nephrology Fellowship

More information

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at Cervical Cancer & HPV What is HPV Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. About HPV Theree are more than 100 types of HPV, of which at least 13 are cancer-causing

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Microbiology Department Crawley Hospital West Green Drive Crawley RH11 7DH United Kingdom Contact: Clare Reynolds Tel: +44 (0) 1293 600379

More information

p. 111 p. 185 p. 197 p. 238

p. 111 p. 185 p. 197 p. 238 Editorial Board Contributors Preface General Methods p. 1 General Methods: Antibody-Based and Molecular p. 3 Introduction p. 5 Antibody-Based Methods p. 6 p. xiii p. xv p. xxv Introduction to Molecular

More information

PRODUCT RANGE

PRODUCT RANGE PRODUCT RANGE 2010-2011 MICROBIOLOGY - VIROLOGY Q - CMV Real Time Complete kit 96 RTK015 Detection of CMV DNA (MIEA) 4 Plasmidic controls at known titre for quantitative assays and CPE-DNA included in

More information

Annual Epidemiological Report

Annual Epidemiological Report September 2018 Annual Epidemiological Report Key Facts Viral Meningitis, not 1 otherwise specified, in Ireland, 2017 In 2017, 259 cases of viral meningitis (NOS) (VM) were notified in Ireland (5.4/100,000

More information

Viral Antigens Recombinant Proteins. Life Science, Inc. Large Scale Manufacturing, R&D and Custom Services.

Viral Antigens Recombinant Proteins. Life Science, Inc. Large Scale Manufacturing, R&D and Custom Services. Viral Antigens Recombinant Proteins Large Scale Manufacturing, R&D and Custom Services Life Science, Inc. www.meridianlifescience.com Life Science, Inc. Meridian Life Science, (MLS) is an industry leader

More information

INFECTIOUS DISEASES PROCEDURE

INFECTIOUS DISEASES PROCEDURE INFECTIOUS DISEASES PROCEDURE Policy Hierarchy link Responsible Officer Contact Officer Superseded Documents Associated Documents Children (Education and Care Services National Law Application) Act 2010

More information

Sustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care. Presenter: Malinda Boehler, MSW, LCSW 15 March 2017

Sustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care. Presenter: Malinda Boehler, MSW, LCSW 15 March 2017 Sustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care Presenter: Malinda Boehler, MSW, LCSW 15 March 2017 Routine HIV Screening in Community Health Centers: Making the

More information

How to Develop an Effective Utilization Management Program. My background. Learning Objectives

How to Develop an Effective Utilization Management Program. My background. Learning Objectives How to Develop an Effective Utilization Management Program Robert L Schmidt, MD, PhD, MBA Department of Pathology & ARUP Laboratories, University of Utah Director, Center for Evidence-Based Testing Medical

More information

Opioid Treatment Program Reimbursement Re-bundling Proposal

Opioid Treatment Program Reimbursement Re-bundling Proposal Opioid Treatment Program Reimbursement Re-bundling Proposal Maryland Department of Health and Mental Hygiene April 22, 2016 The Department reviewed close to 50 letters and emails submitted by stakeholders

More information

A007 Allergy Basic Profile (28 parameters) 5 ml Plain Blood/Serum week BPGM

A007 Allergy Basic Profile (28 parameters) 5 ml Plain Blood/Serum week BPGM B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause

More information

Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma

Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Indication: Treatment of patients with Cutaneous Lymphoma (Unlicensed use) Disease control prior to Reduced Intensity Conditioning Stem Cell Transplant

More information

Economic Evaluation. Defining the Scope of a Costeffectiveness

Economic Evaluation. Defining the Scope of a Costeffectiveness Economic Evaluation Defining the Scope of a Costeffectiveness Analysis II This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes

More information